Ireland
--:--IST
Clinical Trials in the EU / 2026-527325-35-00
Ended Phase I

Bioequivalence clinical trial of two formulations of empagliflozin/metformin

2026-527325-35-00 · tracked via the Priya Life Science EU tracker
Sponsor
Laboratorios Normon S.A
Sponsor type
Pharmaceutical company
Therapeutic area
Not possible to specify
Decision date
26/08/2026
Enrollment target
30
Sites
Spain

Condition studied

Healthy volunteers

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-527325-35-00 on CTIS ↗ ← All trials in the EU